Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Al/ML Data sets
new
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA Grants Orphan Drug Designation to Quemliclustat in Pancreatic Cancer
Quemliclustat plus gemcitabine and nab-paclitaxel chemotherapy outperformed median OS benchmarks in patients with metastatic PDAC.
FDA-approved drug can reduce post-surgery pain without heavy opioid use
Researchers at the Medical University of South Carolina have made a breakthrough in pain management.
CTO East Coast 2025
CTO East Coast 2025: Global oncology cell therapy market to hit $25bn by 2031
FDA accepts new supplemental biologics license application for review for Winrevair
The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with advanced pulmonary arterial hypertension, according to a press release from...
China's Everest Medicines
China's Everest Medicines Unveils Positive Preclinical Validations of In Vivo CAR-T Program
Harmony Biosciences Preclinical Data for Narcolepsy Drug BP1.15205 Shows Promise
Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) is one of the most undervalued small-cap stocks to buy according to analysts.
Klotho Neurosciences’ ALS therapy awarded FDA Orphan Drug Designation
Klotho Neurosciences announced that its novel therapy KLTO-202, also known as s-KL-AAV.myo, for the treatment of Amyotrophic Lateral Sclerosis (ALS) has received Orphan
Trump’s 200% tariff
Trump’s 200% tariff threat could send shockwaves through pharma supply chains
Merck spends $10 billion for Verona, gaining access to its COPD medication
Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal.
Artelo Biosciences’ ART12.11
Artelo Biosciences’ ART12.11 Shows Promising Antidepressant Effects in Preclinical Study
Silo Pharma Advances PTSD Drug SPC-15
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
Cyclacel announces publication of preclinical data on plogosertib
Cyclacel Pharmaceuticals (CYCC) highlighted a publication from independent investigators titled, “DNAJ-PKAc fusion heightens PLK1 inhibitor sensitivity in fibrolamellar carcinoma,” publish...
1
2
3
4
5
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Al/ML Data sets
Synthetic and Medicinal Chemistry
In silico drug design (CADD)
Discovery biology
ADME, DMPK
Functional ex vivo and in vivo models
Safety and Toxicology
Company
News & Media
Contact us
Trends in discovery compounds